Skip to main content

Intimate Partner Violence

0
Pipeline Programs
4
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
6 programs
F4CN/A1 trial
FCCN/A1 trial
Fathers for ChangeN/A1 trial
GBEN/A1 trial
ROSE ProgramN/A1 trial
+1 more programs
Active Trials
NCT04165291Completed60Est. Aug 2023
NCT06071299Active Not Recruiting200Est. Dec 2026
NCT06074068Recruiting1,080Est. Dec 2028
+3 more trials
Alliance Pharmaceuticals
1 program
Cognitive-Behavioral InterventionN/A1 trial
Active Trials
NCT03333798Unknown200Est. Jan 2019
Sigrid Therapeutics
Sigrid TherapeuticsSweden - Stockholm
1 program
SASA!N/A1 trial
Active Trials
NCT00790959Unknown800Est. May 2012
Young BioPharma
Young BioPharmaMA - Lowell
1 program
ePREPN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Human BioSciencesGBE
Human BioSciencesFathers for Change
Human BioSciencesFCC
Human BioSciencesF4C
Alliance PharmaceuticalsCognitive-Behavioral Intervention
Human BioSciencesROSE Program
Human BioSciencesePREP
Sigrid TherapeuticsSASA!

Clinical Trials (8)

Total enrollment: 4,197 patients across 8 trials

NCT06811922Human BioSciencesGBE

The Primary Prevention of Intimate Partner Violence

Start: Feb 2026Est. completion: Oct 20271,700 patients
N/ANot Yet Recruiting
NCT06074068Human BioSciencesFathers for Change

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Start: Jan 2024Est. completion: Dec 20281,080 patients
N/ARecruiting
NCT06071299Human BioSciencesFCC

Impact of Family-Centered Care for Intimate Partner Violence (IPV)

Start: Jan 2024Est. completion: Dec 2026200 patients
N/AActive Not Recruiting
NCT04165291Human BioSciencesF4C

Comparing a Fatherhood Focused Individual Intervention to Batterer Intervention to Reduce IPV and Child Maltreatment

Start: Sep 2020Est. completion: Aug 202360 patients
N/ACompleted
NCT03333798Alliance PharmaceuticalsCognitive-Behavioral Intervention

Psychosocial Intervention With Community Worker Support for Survivors of Intimate Partner Violence

Start: Nov 2017Est. completion: Jan 2019200 patients
N/AUnknown
NCT02370394Human BioSciencesROSE Program

Intervention for IPV Perinatal Women- RCT

Start: Mar 2015Est. completion: Sep 201653 patients
N/ACompleted
NCT01795963Human BioSciencesePREP

ePREP for Community Couples

Start: Jun 2009Est. completion: Aug 2010104 patients
N/ACompleted
NCT00790959Sigrid TherapeuticsSASA!

The SASA! Study: An Evaluation of a Community Intervention to Address Gender-based Violence and Reduce HIV/AIDS Risk in Uganda

Start: Oct 2007Est. completion: May 2012800 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 4,197 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.